XLV News 60.21 10/17/2014 06:06:23 Healthcare Select Sector SPDR

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Healthcare Select Sector SPDR (XLV) 60.21 $XLV

Healthcare ETFs in Focus on JNJ Earnings Beat - ETF News And Commentary
Sweta Killa - ZACKS - Wed Oct 15, 12:00PM CDT
Investors should take a close look to healthcare ETFs following Johnson & Johnson earnings beat.
JNJ: 96.78 (-1.43), PPH: 58.24 (-0.34), IYH: 126.91 (-0.17), GILD: 96.88 (+0.72), ABBV: 52.90 (-1.73), XLV: 60.21 (-0.31)

3 Best Performing Mutual Funds of 2014 - Mutual Fund Commentary
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 10:41AM CDT
For investors keen to find out the best performing funds so far this year, we will pick 3 of them based on top Zacks rank, no sales load and low expense ratio.
ACT: 222.07 (+4.83), MCK: 185.32 (+0.30), TOT: 54.85 (-0.43), BRCM: 35.31 (-0.15), TXN: 43.59 (+0.83), JNS: 14.10 (+0.20), XOM: 90.60 (+0.38), BP: 40.72 (+0.09), INTC: 30.85 (-0.42), XLU: 42.75 (+0.04), XLV: 60.21 (-0.31)

Bull of the Day: Acadia Healthcare (ACHC) - Bull of the Day
Kevin Cook - Zacks Investment Research - Thu Oct 02, 1:51AM CDT
Bull of the Day: Acadia Healthcare (ACHC) - Bull of the Day
ACHC: 50.27 (+1.52), XLV: 60.21 (-0.31)

Healthcare ETFs for your Portfolio's Wellness - ETF News And Commentary
Neena Mishra - ZACKS - Fri Sep 26, 10:56AM CDT
Healthcare sector has been beating the broader market and looks well poised to continue its outperformance in the longer term.
PJP: 61.24 (+0.58), VHT: 110.92 (-0.20), XLV: 60.21 (-0.31)

Sigma-Aldrich Hits High On Sale To Germany's Merck
at Investor's Business Daily - Mon Sep 22, 10:30AM CDT
Shares of Sigma-Aldrich (SIAL), a major provider of chemicals and other products for the life-science industry, jumped more than 34% to an all-time high near 138 in the stock market today after German drugmaker Merck KGaA announced it's buying the...
A: 51.71 (-0.08), TMO: 109.69 (-1.45), SIAL: 134.40 (-0.75), MRK: 53.43 (-1.30), ILMN: 160.23 (+6.64), WAT: 95.12 (+0.04), XLV: 60.21 (-0.31)

Which Sectors Are You Betting On? - Real Time Insight
Todd Bunton - ZACKS - Wed Aug 13, 3:35PM CDT
Which sectors do you think will outperform or underperform throughout the rest of 2014?
XTN: 87.99 (+1.41), XLY: 63.24 (+0.07), XLF: 22.04 (unch), XLV: 60.21 (-0.31)

Bet On This Top Ranked Medical Device ETF - ETF News And Commentary
Zacks Equity Research - ZACKS - Mon Aug 11, 5:07AM CDT
This top ranked ETF may be a good defensive bet in the current volatile market environment.
ABT: 39.99 (-0.02), XPH: 102.27 (+1.21), IHI: 97.65 (-0.70), XLV: 60.21 (-0.31)

Healthcare ETFs Leading the Pack This Q2 Earnings - ETF News And Commentary
Sweta Killa - ZACKS - Thu Aug 07, 1:00PM CDT
These healthcare ETFs are crushing the broad market on Q2 earnings growth.
RYH: 123.99 (-0.21), IHF: 104.01 (+1.68), SPY: 186.27 (-0.16), XHS: 100.82 (+1.26), XLV: 60.21 (-0.31)

Interesting XLV Put And Call Options For September 26th
DividendChannel.com - Thu Aug 07, 10:19AM CDT
Investors in Health Care Select Sector SPDR Fund saw new options become available today, for the September 26th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the XLV options chain for the new September 26th...
XLV: 60.21 (-0.31)

Skip Sales Load: 3 Top No-Load Funds to Buy - Best of Funds
Zacks Equity Research - Zacks Investment Research - Fri Jul 25, 10:59AM CDT
Energy, Utilities and Healthcare sectors currently fill the top 3 slots for the best gains year to date among the S&P 500 industry groups. We are going to share with you 3 Zacks #1 (Strong Buy) no-load funds from each sector.
XLU: 42.75 (+0.04), XLV: 60.21 (-0.31), XLE: 82.00 (+1.44)

Healthcare ETFs in Focus on JNJ Earnings - ETF News And Commentary
Sweta Killa - ZACKS - Wed Jul 16, 12:00PM CDT
Johnson & Johnson’s earnings beat and concern over the sustainable sales growth put healthcare ETFs in focus.
JNJ: 96.78 (-1.43), PPH: 58.24 (-0.34), IYH: 126.91 (-0.17), XLV: 60.21 (-0.31)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Copper Peptides Shine in New Renue Blue Cream

Updated Category News Views 171

Renue By Science's Ambitious Skincare Launch Alright, we've got a big player stepping up in the realm of skincare with a new face cream packed tightly with science-backed goodies. Renue By Science is revamping their game by anchoring their new Renue Blue Face Cream around the star of the moment: copper tripeptide-1, also known as GHK-Cu. This is more than a beauty gloss...

Continue Reading
Alley Cat Allies Pushes for Humane Cat Conservation Bill

Updated Category News Views 70

Time to Rethink Conservation: Save the Cats If you’re tuned into the chatter buzzing around the Cayman Islands, you know the clocks are ticking for a decision that could change the approach to handling community cats. Alley Cat Allies is waving the flag, urging the Cayman Islands Parliament to pass a bill that abandons the archaic practice of culling cats by shooting...

Continue Reading
Cognito Unveils Phase 3 Results for Alzheimer Treatment

Updated Category News Views 292

Charting New Waters in Alzheimer's Treatment Well, here's one for the books, folks. Cognito Therapeutics just tossed their latest Phase 3 results from their so-called HOPE study into the ring. We're talking about Spectris AD, a non-drug, at-home gizmo that aims to be the next big thing for Alzheimer's. Yeah, the study didn't exactly hit a home run with the primary...

Continue Reading
Endava's Audit Scandal: Investors Face Crucial Decision

Updated Category News Views 156

Endava's Unexpected Crisis: What's Happening? It's the kind of mess no investor wants to wake up to: on October 28, 2026, Endava plc (NYSE: DAVA) laid out a smorgasbord of screw-ups that have left the market reeling. The company's last few days were a whirlwind, featuring the CFO's abrupt exit and the CEO swap. This shake-up didn't happen in isolation—the announcement...

Continue Reading
Peptide Tracker Refresh Unveils New Planning Features

Updated Category News Views 136

Peptide Tracker's Latest Updates: A Game Changer? I'll tell you what—if you're keeping tabs on your peptide intake like a seasoned gardener checks the soil, Peptide Tracker's fresh versions 3.2.0 and 3.3.0 might just be your new best mates. With the addition of washout scheduling and a robust six-month schedule preview, this isn't just another fancy tech update. It's...

Continue Reading
Kos & FORTH Partner to Spark Greek Biotech Growth

Updated Category News Views 81

New Frontiers: Greece on the Biotech Map Partnerships in biotech aren't tossed out willy-nilly; they're crafted for precision much like a sculptor shaping marble. Kos Biotechnology Partners and the Foundation for Research and Technology-Hellas (FORTH) are doing exactly that, teaming up to birth a biotechnology incubator on the FORTH campus in Heraklion, Crete. Now tell...

Continue Reading
Local Bounti Expands: Acquires CEA Facilities

Updated Category News Views 72

Local Bounti's Strategic Acquisition Move Local Bounti's at it again, shaking up the indoor agriculture scene by snapping up some real estate from Revol Greens. We're talking 30 acres of primo certified-organic greenhouse space across Texas and Minnesota. And they’re picking these babies up right as they’re ready to grow, not like some flashy land grab. Digging into...

Continue Reading
Quantum X and Everest Cloud Partner in South Asia Push

Updated Category News Views 108

An Unlikely Alliance for Cutting-Edge Tech You gotta admit, the fusion of a U.S.-based tech outfit with a Nepalese cloud provider wasn't the market move anyone saw coming. But here we are—Quantum X is hitching its quantum computing dreams to Everest Cloud's solid local foothold across six South Asian markets. We're talking Nepal, India, Bangladesh, Bhutan, Sri Lanka,...

Continue Reading
BWIN Acquisition Under Scrutiny: Shareholders Alerted

Updated Category News Views 118

BWIN Shareholders in the Hot Seat Over Acquisition Ever feel like you're the last one to know when the music stops in this investing dance? Well, if you're holding shares of The Baldwin Insurance Group, Inc. (NASDAQ:BWIN), it's time to put down your coffee and tune in. Levi & Korsinsky, LLP threw a wrench in the works, launching an investigation to see if this Sequence...

Continue Reading
Apotex Enters U.S. Market with Axitinib Tablets Launch

Updated Category News Views 114

Apotex's Bold Move: Axitinib Tablets Hit the U.S. Market Apotex is shaking things up in the pharma world by launching the first generic version of Axitinib Tablets in the U.S., aimed at treating advanced renal cell carcinoma (RCC) when previous treatments have fallen flat. This isn't just another dance with the red tape—it's a major step for Apotex, flexing their muscle...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Natural Hydrogen: MAX Power Mining's Vision

Updated Category News Views 184

MAX Power Mining Corp. Driving Innovation in Natural Hydrogen In an era where energy demands are escalating, especially with the rise of artificial intelligence and advanced technologies, the search for sustainable power sources has reached new heights. Enter MAX Power Mining Corp. (OTC: MAXXF) (CSE: MAXX), a trailblazer in the natural hydrogen sector, demonstrating...

Continue Reading
Inland Empire Health Plan Achieves Excellence in GIS Recognition

Updated Category News Views 246

A Celebration of Achievement for Inland Empire Health Plan Inland Empire Health Plan (IEHP) has achieved remarkable recognition by winning its third Special Achievement in GIS (SAG) award from Esri, the global leader in Geographic Information System (GIS) technology. This prestigious accolade highlights IEHP's commitment to utilizing innovative technology to enhance...

Continue Reading
Ryp Labs Triumphs in Lineage’s Global Food Innovation Challenge

Updated Category News Views 226

Ryp Labs Triumphs in Lineage’s Global Food Innovation Challenge In a groundbreaking moment for sustainable food technology, Ryp Labs was announced as the standout winner of Lineage's prestigious innovation challenge aimed at transforming the global food supply chain. The challenge focused on innovative solutions that address pressing issues such as food waste and supply...

Continue Reading
Future Landscape of the UV Stabilizers Market by 2032

Updated Category News Views 176

Growth of the UV Stabilizers Market The UV stabilizers market is gaining momentum, projected to expand from USD 1.4 billion to USD 2.3 billion by 2032, with a compound annual growth rate (CAGR) of 5.5% during the 2024-2032 period. This growth is fueled by the increasing demand for materials that are durable and can endure the degrading effects of ultraviolet (UV)...

Continue Reading
Dr. Rushika Fernandopulle Joins Premera Board of Directors

Updated Category News Views 337

Dr. Rushika Fernandopulle Joins Premera's Board Premera Blue Cross is excited to announce the addition of Dr. Rushika Fernandopulle to its Board of Directors. This decision is part of a strategic effort to strengthen leadership and expertise within the organization. Dr. Fernandopulle takes over from Dr. John Jenrette, who has completed his term this year. Expertise and...

Continue Reading